Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma

S. A. M. van de Schans, A. N. M. Wymenga, D. J. van Spronsen, H. C. Schouten, J. W. W. Coebergh, M. L. G. Janssen-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1280-1286
JournalAnnals of Oncology
Issue number5
Publication statusPublished - May 2012


  • diffuse large B-cell lymphoma
  • elderly
  • population-based
  • toxicity
  • treatment
  • survival

Cite this